"Hand-foot" syndrome-an unusual case of plantar pathology presenting to a burns unit.
Hand-foot or palmar-plantar erythrodysesthesia syndrome is an infrequent complication of chemotherapy treatment. Patients present to a variety of disciplines, including burns specialists for treatment. The majority of patients respond to a combination of appropriate adjustments to their chemotherapy regimen and topical supportive therapy to the affected areas. We report a case of the syndrome referred for assessment and treatment to our burns unit and overview the differential diagnoses of palmar/plantar epidermal loss.
St. Andrew's Centre for Plastic Surgery and Burns, East Wing, Broomfield Hospital, Court Road, Chelmsford, United Kingdom.
Ioannis
I
Goutos
Magdalini
M
Kaniorou-Larai
Peter
P
Dziewulski
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D002053:Burn Units; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005528:Foot; D006225:Hand; D006801:Humans; D008297:Male; D012871:Skin Diseases / Q000139:chemically induced* / Q000628:therapy*; D013577:Syndrome
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil